Tomocube, a company specializing in holotomography-based technology, announced that its latest product, the HT-X1 Plus, has received the "Microscopy Today Innovation Award 2025." This award, organized by the Microscopy Society of America (MSA), is one of the most prestigious honors in the field of microscopy, selecting only the top 10 innovative products worldwide each year.
The Microscopy Today Innovation Award is presented annually to new products that demonstrate both technological innovation and practical utility. This year, Tomocube became the first company in Asia to win the award twice, following its previous win in 2019. Tomocube had previously showcased its technological prowess and innovation to the world by winning the award in 2019 with its HT-2H product.
This latest recognition signifies that the HT-X1 Plus has been acknowledged for its innovation and research efficiency that surpass existing technologies, further solidifying Tomocube's position as a leading global innovator in bioimaging.
The HT-X1 Plus represents a next-generation model that advances beyond first-generation holotomography products using lasers, by commercializing second-generation holotomography technology based on LEDs.
This product is built on label-free 3D imaging technology that allows observation of cells without staining. It integrates fluorescence imaging and AI-based quantitative analysis into a single platform, greatly enhancing convenience and analytical efficiency for researchers. In particular, it has garnered significant attention for enabling precise measurement of 3D biological samples such as organoids and embryos, which were previously difficult to analyze with conventional microscopy technologies.
Notably, the HT-X1 Plus is integrated with spinning-disc confocal fluorescence microscopy technology, providing simultaneous access to both fluorescence information of intracellular molecules and three-dimensional structural data of cells. Just as combining PET with CT to create PET/CT produces a synergistic effect compared to using CT alone, the integration of holotomography with confocal fluorescence microscopy creates a powerful synergy.
This enables more precise understanding and analysis of structural changes and functions within cells, significantly improving experimental efficiency for researchers in life sciences and precision medicine.
The HT-X1 Plus features multimodal imaging integration, allowing real-time implementation of various imaging techniques?including fluorescence microscopy, confocal microscopy, and holotomography?on a single platform. In particular, its high-speed multiwell plate scanning capability allows analysis of 96 samples in under 30 minutes, providing a more efficient experimental environment for pharmaceutical and biotechnology clients.
Park Yongkeun, CEO of Tomocube, stated, "This award signifies that the innovative technology of the HT-X1 Plus has been recognized globally. We will continue to strengthen our position as a global leader in the bio and medical fields through ongoing research and development."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
